Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonistsP J Hesketh, S Van Belle, M Aapro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesisP J Hesketh, R J Gralla, R T Webb, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimenP J Hesketh, T Beck, M Uhlenhopp, et al.Bone Marrow Transplantation|January 10, 2002
Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell supportK K Ballen, A M Hesketh, C Heyes, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1996
Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamideP J Hesketh, D R Gandara, A M Hesketh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesisP J Hesketh, W K Murphy, E P Lester, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesisP J Hesketh, W H Harvey, W G Harker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomitingT M Beck, P J Hesketh, S Madajewicz, et al.Cancer|March 15, 1997
Randomized, double blind, dose-response trial across four oral doses of dolasetron for the prevention of acute emesis after moderately emetogenic chemotherapy. Oral Dolasetron Dose-Response Study GroupE B Rubenstein, R J Gralla, J D Hainsworth, et al.International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Paclitaxel and concurrent radiation for gastric cancerH Safran, H J Wanebo, P J Hesketh, et al.Pageof 6